[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Women's Health - Medical Devices Pipeline Assessment, 2019

December 2019 | 603 pages | ID: W7F19146C793EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Women's Health - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Women’s Health - Medical Devices Pipeline Assessment, 2019' provides an overview of Women’s Health currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Women’s Health pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Women’s Health under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Women’s Health and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Women’s Health under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Women's Health Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Women's Health - Pipeline Products by Stage of Development
3.2 Women's Health - Pipeline Products by Territory
3.3 Women's Health - Pipeline Products by Regulatory Path
3.4 Women's Health - Pipeline Products by Estimated Approval Date
3.5 Women's Health - Ongoing Clinical Trials

4 WOMEN'S HEALTH - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Women's Health Companies - Pipeline Products by Stage of Development
4.2 Women's Health - Pipeline Products by Stage of Development

5 WOMEN'S HEALTH COMPANIES AND PRODUCT OVERVIEW

5.1 AblaCare Company Overview
  5.1.1 AblaCare Pipeline Products & Ongoing Clinical Trials Overview
5.2 AdneXXA LLC Company Overview
  5.2.1 AdneXXA LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced Prenatal Therapeutics, Inc. Company Overview
  5.3.1 Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Advanced Tactile Imaging Inc Company Overview
  5.4.1 Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 AEGEA Medical Inc Company Overview
  5.5.1 AEGEA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Aethlon Medical Inc Company Overview
  5.6.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Agile Therapeutics Inc Company Overview
  5.7.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Allergan Plc Company Overview
  5.8.1 Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
5.9 AltaScience Limited Company Overview
  5.9.1 AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview
5.10 Alydia Health Inc Company Overview
  5.10.1 Alydia Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Amniotix Technologies Ltd Company Overview
  5.11.1 Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 ANALYTICA PTY LTD Company Overview
  5.12.1 ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview
5.13 Aneeve Nanotechnologies LLC Company Overview
  5.13.1 Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 Aspivix SA Company Overview
  5.14.1 Aspivix SA Pipeline Products & Ongoing Clinical Trials Overview
5.15 Bayer AG Company Overview
  5.15.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
5.16 Baystate Medical Center Company Overview
  5.16.1 Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.17 Becton Dickinson and Co Company Overview
  5.17.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
5.18 BeFree! Company Overview
  5.18.1 BeFree! Pipeline Products & Ongoing Clinical Trials Overview
5.19 BellaSeno GmbH Company Overview
  5.19.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.20 Bewell Connect Corp Company Overview
  5.20.1 Bewell Connect Corp Pipeline Products & Ongoing Clinical Trials Overview

6 WOMEN'S HEALTH- RECENT DEVELOPMENTS

6.1 Nov 19, 2019: Edan to highlight its new developments at MEDICA 2019
6.2 Nov 19, 2019: Clinical Innovations hires Rebecca Liu as VP, general manager for CI Medical Instruments in China
6.3 Nov 18, 2019: A new self-use innovative treatment for pelvic organ prolapse in women (POP) designed by ConTIPI Medical
6.4 Nov 18, 2019: Barbro Friden steps down as a member of the board of Vitrolife
6.5 Nov 14, 2019: Merck acquires Calporta Therapeutics for $576m
6.6 Nov 14, 2019: INVO Bioscience reports third quarter 2019 financial results
6.7 Nov 13, 2019: BellaSeno and Evonik to launch 3D-printed absorbable breast scaffold
6.8 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories
6.9 Nov 13, 2019: Atossa Genetics announces third quarter 2019 financial results and provides company update
6.10 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Women's Health - Pipeline Products by Stage of Development
Table 2: Women's Health - Pipeline Products by Territory
Table 3: Women's Health - Pipeline Products by Regulatory Path
Table 4: Women's Health - Pipeline Products by Estimated Approval Date
Table 5: Women's Health - Ongoing Clinical Trials
Table 6: Women's Health Companies - Pipeline Products by Stage of Development
Table 7: Women's Health - Pipeline Products by Stage of Development
Table 8: AblaCare Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AblaCare Kit - Product Status
Table 10: AblaCare Kit - Product Description
Table 11: AblaCare - Ongoing Clinical Trials Overview
Table 12: AblaCare Kit - ULTRA Study: A Feasibility, Prospective, Multicenter, Single-arm Trial of the AblaCare Device in Transvaginal Ablation of Ovarian Tissue Under Ultrasound Visualisation in Women with Polycystic Ovary Syndrome (PCOS)
Table 13: AdneXXA LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Reusable Contraception Device - Product Status
Table 15: Reusable Contraception Device - Product Description
Table 16: Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Targeted Apheresis Column for Preeclampsia (TAC-PE) - Product Status
Table 18: Targeted Apheresis Column for Preeclampsia (TAC-PE) - Product Description
Table 19: Advanced Tactile Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Antepartum Tactile Imager - Product Status
Table 21: Antepartum Tactile Imager - Product Description
Table 22: Cervix Monitor - Product Status
Table 23: Cervix Monitor - Product Description
Table 24: Restore-IT - Product Status
Table 25: Restore-IT - Product Description
Table 26: AEGEA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Next-Generation Adaptive Vapor Ablation System - Product Status
Table 28: Next-Generation Adaptive Vapor Ablation System - Product Description
Table 29: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: HER2osome - Product Status
Table 31: HER2osome - Product Description
Table 32: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: AG200-ER Patch - Product Status
Table 34: AG200-ER Patch - Product Description
Table 35: AG200-SP Patch - Product Status
Table 36: AG200-SP Patch - Product Description
Table 37: AG890 Patch - Product Status
Table 38: AG890 Patch - Product Description
Table 39: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Norethindrone Transdermal Delivery System - Product Status
Table 41: Norethindrone Transdermal Delivery System - Product Description
Table 42: Smooth 133 Plus TE - Product Status
Table 43: Smooth 133 Plus TE - Product Description
Table 44: AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 45: AltaSeal - Product Status
Table 46: AltaSeal - Product Description
Table 47: Alydia Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: InPress Postpartum Hemorrhage Intrauterine Device - Product Status
Table 49: InPress Postpartum Hemorrhage Intrauterine Device - Product Description
Table 50: Alydia Health Inc - Ongoing Clinical Trials Overview
Table 51: InPress Postpartum Hemorrhage Intrauterine Device - Potential Approach to Treat Postpartum Hemorrhage Using InPress Postpartum Hemorrhage Intrauterine Device
Table 52: InPress Postpartum Hemorrhage Intrauterine Device - Prospective, Single Arm Pivotal Clinical Trial Designed to Assess the Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
Table 53: Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Amniotic Fluid Spectral Monitoring Device - Product Status
Table 55: Amniotic Fluid Spectral Monitoring Device - Product Description
Table 56: ANALYTICA PTY LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 57: PeriCoach System - Pelvic Organ Prolapse - Product Status
Table 58: PeriCoach System - Pelvic Organ Prolapse - Product Description
Table 59: Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Hormone Level Monitor - Product Status
Table 61: Hormone Level Monitor - Product Description
Table 62: Aspivix SA Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Aspivix Device - Product Status
Table 64: Aspivix Device - Product Description
Table 65: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 66: LNG-IUS16 - Product Status

LIST OF FIGURES

Figure 1: Women's Health - Pipeline Products by Stage of Development
Figure 2: Women's Health - Pipeline Products by Territory
Figure 3: Women's Health - Pipeline Products by Regulatory Path
Figure 4: Women's Health - Pipeline Products by Estimated Approval Date
Figure 5: Women's Health - Ongoing Clinical Trials

COMPANIES MENTIONED

AblaCare
AdneXXA LLC
Advanced Prenatal Therapeutics, Inc.
Advanced Tactile Imaging Inc
AEGEA Medical Inc
Aethlon Medical Inc
Agile Therapeutics Inc
Allergan Plc
AltaScience Limited
Alydia Health Inc
Amniotix Technologies Ltd
ANALYTICA PTY LTD
Aneeve Nanotechnologies LLC
Aspivix SA
Bayer AG
Baystate Medical Center
Becton Dickinson and Co
BeFree!
BellaSeno GmbH
Bewell Connect Corp
Bioceptive Inc
BiolMed Innovations Pvt Ltd
Biorings LLC
Biostruxs LLC
BioTex Inc
Birmont Medical Ltd.
Bloomlife, Inc.
Cambridge Consultants Ltd
Cambridge Design Partner Ltd.
Cath Med Ltd.
Ceragenix Pharmaceuticals, Inc. (Inactive)
CervoCheck, LLC
Citius Pharmaceuticals LLC
CommonSense Ltd.
Concepta PLC
Contrel Europe NV
CrossBay Medical Inc
Dare Bioscience Inc
Dartmouth College
DermaDiagnostics
Discreet Secrete Solutions
DS Labs, Inc
Earth Science Tech Inc
Emory University
Enox Biopharma Inc (Inactive)
EVE Medical Systems Ltd
Evestra Inc
Evofem Biosciences Inc
Femasys Inc
FemSuite LLC
Ferring Pharmaceuticals AS
Fibro Control (Israel) Ltd (Inactive)
Fotona LLC
FP Medtech Inc
Global Health Partnerships
Grunenthal Ltd
Haemek Medical Center
Healingstone Co Ltd
Healthcare Enterprise Group PLC (Inactive)
Hera Health Solutions
Hera Med Ltd
Herbio Co Ltd
HLL Lifecare Ltd
Hong Kong Polytechnic University
Igantia Therapeutics
Imperial College London
Impres Medical, Inc.
In Veritas Medical Diagnostics Inc (Inactive)
Innometrix
J3 Bioscience Inc
Janitri Innovations Pvt Ltd
Jibon Health Technologies, Inc.
Johns Hopkins University
Joylux Inc
Keratin Biosciences Inc
KynderMed Inc
Laboratoire HRA Pharma SAS
Laboratorios Andromaco
Lady Technologies Inc
LifeCell Corp
Lyra Medical Ltd
Madorra
Magee-Womens Research Institute
Materna Medical Inc.
Maziwa
McGill University Health Center
Meccellis Biotech
Medela AG
MEDITE Cancer Diagnostics Inc
Medprin Regenerative Medical Technologies Co Ltd
MenoPal
Merck & Co Inc
Merck KGaA
Merck Serono SA
MFB Fertility Inc
Miltenyi Biotec GmbH
Mithra Pharmaceuticals SA
Momtec Life Ltd.
Myant Inc
Nagasaki University
NipaYe
Nipro Corp
Northwestern University
Novela Inc
Noventure S.L.
Novomedics L L C
OB Smart Ltd
ObsteCare AB
OCON Medical Ltd
OmniBiome Therapeutics Inc
OncoGenesis
Ondine Biomedical Inc
Onko Solutions, LLC
OOVA Inc
ORATEL DIAGNOSTICS LLC
Orion Biotechnology Canada Ltd
Os Technology LLC
Otago Innovation Ltd
PearlPod LLC
PEPTONIC medical AB
Pfizer Inc
Plus Therapeutics Inc
Polumiros Inc
Polytechnic University of Catalonia
Positive Care Ltd
PregnanTech Ltd
Prima-Temp, Inc
Purdue University
Qurasense Inc
Rambam Health Care Campus
Reia LLC
Renovia Inc
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
RevMedx, Inc.
Rice University
Samplytics Technologies Pvt Ltd
Sebela Pharmaceuticals
Soulor Surgical Inc (Inactive)
Stanford University
Starpharma Holdings Ltd
Tecuro AG
Tentan AG
TeVido BioDevices LLC
Texas A&M University
The Cooper Companies Inc
The Feinstein Institute for Medical Research
TruScreen Ltd
University of Auckland
University of California San Francisco
University of Duisburg-Essen
University of Erlangen-Nurnberg
University of Florida
University of Liverpool
University of Maryland Baltimore
University of Minnesota
University of Pittsburgh
University of Sheffield
University of South Florida
University of Texas Health Science Center at San Antonio
University of Utah
University of Waterloo
VeriTeQ Corporation
Virginia Commonwealth University
VivoPlex Ltd
Yale University
Zambon Italia Srl
ZR-Operculum, Inc.


More Publications